SCHEMBL19658641

SCHEMBL19658641

CC(=O)NC1CCN(c2ccncn2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 1/20 0.53
SKP1 P63208 1/20 0.53
SKP2 Q13309 1/20 0.53
GPR119 Q8TDV5 1/20 0.53
SMO Q99835 1/20 0.48
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
CNR1 P21554 1/20 0.46
RIPK1 Q13546 1/20 0.46
LSS P48449 1/20 0.44
SORD Q00796 1/20 0.44
AKT1 P31749 2/20 0.43
PIK3CA P42336 1/20 0.43
MTOR P42345 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
F10 P00742 1/20 0.42
GRM1 Q13255 1/20 0.42
ROCK1 Q13464 1/20 0.41
STK4 Q13043 1/20 0.41
STK3 Q13188 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27920367 0.87 GPR119 (0.51) CKS1BSKP1SKP2GPR119CCNC
SCHEMBL24015528 0.86 CHRM4 (0.53) CKS1BSKP1SKP2GPR119CCNC
SCHEMBL19652122 0.85 GPR119 (0.50) GPR119CCNCCDK8CNR1RIPK1
SCHEMBL2273767 0.82 GPR119 (0.65) CKS1BSKP1SKP2GPR119CCNC
SCHEMBL2301058 0.82 CKS1B (0.60) CKS1BSKP1SKP2GPR119SMO
SCHEMBL12639924 0.81 GPR119 (0.56) GPR119RIPK1LSSSORDAKT1
SCHEMBL803347 0.81 GPR119 (0.49) GPR119CCNCCDK8RIPK1SORD
Hydrochloric Acid SCHEMBL19639676 0.80 GPR119 (0.48) GPR119CCNCCDK8RIPK1SORD
Hydrochloric Acid SCHEMBL785329 0.80 GPR119 (0.48) GPR119CCNCCDK8RIPK1SORD
SCHEMBL7334224 0.80 DRD2 (0.49) CKS1BSKP1SKP2SMOCCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170340604-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170340604-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF BRD4, BRDT, BRD3 CKS1B 239/4885SKP1 2240/4885SKP2 2256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.